RESTRUCTURING

On an ongoing basis, the Company reviews the global economy, the healthcare industry, and the markets in which it competes to identify opportunities for efficiencies, enhance commercial capabilities, align its resources and offer its customers better solutions. In order to realize these opportunities, the Company undertakes restructuring-type activities to transform its business.

During fiscal 2018, the Company launched a Complexity Reduction Initiative (the "2018 Program"), a company-wide restructuring program designed to improve operational performance and reduce cost, freeing up resources to invest in accelerated growth. This program includes a reduction of headcount and operating costs to enable a more streamlined organizational structure. The Company expects to incur aggregate charges between $50 million and $60 million associated with these actions, of which it expects $35 million to $40 million will consist of severance and other employee costs and the remainder will consist of other exit costs, primarily related to third party services. These charges, substantially all of which will result in cash outlays, will be incurred as the specific actions required to execute on these initiatives are identified and approved and are expected to continue through fiscal 2020. During fiscal 2019 and 2018, the Company incurred $13.7 million and $36.6 million of restructuring and turnaround costs under this program, respectively. Total cumulative charges under this program are $50.3 million as of March 30, 2019.

During fiscal 2017, the Company launched a restructuring program (the "2017 Program") designed to reposition its organization and improve its cost structure. The Company did not incur any charges under this program during fiscal 2019. During fiscal 2018 and 2017, the Company incurred $7.2 million and $28.7 million of restructuring and turnaround charges under this program, respectively. The 2017 Program is substantially complete.

The following table summarizes the activity for restructuring reserves related to the 2018 Program and the 2017 and Prior Programs for the fiscal years ended March 30, 2019, March 31, 2018 and April 1, 2017, substantially all of which relates to employee severance and other employee costs:



(In thousands)	2018 Program			2017 and Prior Programs			Total
Balance at April 2, 2016	$	—		$	8,752		$	8,752
Costs incurred, net of reversals	—			21,833			21,833
Payments	—			(22,317		)	(22,317		)
Non-cash adjustments	—			(800		)	(800		)
Balance at April 1, 2017	$	—		$	7,468		$	7,468
Costs incurred, net of reversals	29,694			835			30,529
Payments	(1,363		)	(6,897		)	(8,260		)
Non-cash adjustments	(1,202		)	—			(1,202		)
Balance at March 31, 2018	$	27,129		$	1,406		$	28,535
Costs incurred, net of reversals	431			(36		)	395
Payments	(20,742		)	(650		)	(21,392		)
Non-cash adjustments	(96		)	37			(59		)
Balance at March 30, 2019	$	6,722		$	757		$	7,479

The substantial majority of restructuring costs during fiscal 2019, 2018 and 2017 have been included as a component of selling, general and administrative expenses in the accompanying consolidated statements of income (loss). As of March 30, 2019, the Company had a restructuring liability of $7.5 million, of which, approximately $6.7 million is payable within the next twelve months.

In addition to the restructuring expenses included in the table above, the Company also incurred costs of $13.2 million, $13.6 million and $12.5 million in fiscal 2019, 2018 and 2017, respectively, that do not constitute as restructuring under ASC 420, Exit and Disposal Cost Obligations, which the Company refers to as turnaround costs. These costs, substantially all of which have been included as a component of selling, general and administrative expenses in the accompanying consolidated statements of income (loss), consist primarily of expenditures directly related to the restructuring actions and include program management costs associated with the implementation of outsourcing initiatives and recent accounting standards.

The tables below present restructuring and turnaround costs by reportable segment:



Restructuring costs
(In thousands)	2019			2018			2017
Japan	$	102		$	514		$	819
EMEA	730			1,496			4,272
North America Plasma	(20		)	565			366
All Other	(417		)	27,954			16,376
Total	$	395		$	30,529		$	21,833

Turnaround costs
(In thousands)	2019			2018			2017
Japan	$	—		$	—		$	2
EMEA	108			(107		)	94
North America Plasma	136			976			972
All Other	12,984			12,727			11,415
Total	$	13,228		$	13,596		$	12,483

Total restructuring and turnaround	$	13,623		$	44,125		$	34,316